About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Los Angeles | 194 Studies

Clinical Trials Breast CancerLos Angeles

Breast Cancer Clinical Trials in Los Angeles

Find 194 clinical trials for breast cancer near Los Angeles, California. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 194 trials

RecruitingStudy of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsThis study will evaluate the safety, tolerability, and preliminary effectiveness of AMXT 1501 and DFMO when combined with standard treatments for advanced solid tumors.NCT07287917·Tucson, Arizona and 19 others TerminatedNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsThe purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors and a pathogenic or likely…NCT05169437·Yuma, Arizona and 79 others

Breast Cancer Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingComparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyThis randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast…NCT01901094·Daphne, Alabama and 1245 others

RecruitingA Study of Breast Cancer Risk Factors and Outcomes of People in FloridaThe purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.NCT06780176·Los Angeles, California and 2 others

Active not recruitingTesting Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast CancerThis Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive…NCT05705401·Phoenix, Arizona and 417 others

CompletedPhase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer PatientsThis is a phase I/II, open-label, multicenter study of AUY922 administered intravenously in patients with advanced solid malignancies to determine the maximum tolerated dose.NCT00526045·Los Angeles, California and 9 others

TerminatedA Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2A Study of XMT-2056 in advanced/recurrent solid tumors that express HER2.NCT05514717·Los Angeles, California and 13 others

CompletedRandomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead InThe purpose of this study is to determine the safety and tolerability of entinostat used in combination with atezolizumab in participants with Advanced Triple Negative Breast…NCT02708680·Birmingham, Alabama and 28 others

Active not recruitingA Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsThis is an open-label, multi-center Phase 1/2 study of oral LOXO-292 in pediatric participants with an activating rearranged during transfection (RET) alteration and an advanced…NCT03899792·Los Angeles, California and 25 others

CompletedPreventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)The purpose of this research study is to see if Atorvastatin (Lipitor) 40 mg by mouth daily decreases the chance of developing heart problems in individuals receiving adjuvant…NCT01988571·Los Angeles, California and 50 others

CompletedOpen-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast CancerOpen-label, Phase II study of Stomatitis prevention with a steroid-based mouthwash in Post-menopausal women with ER+, HER2- Metastatic or Locally Advanced Breast CancerNCT02069093·Fayetteville, Arkansas and 22 others

RecruitingOpen-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsFirst in human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of BBO-10203, a PI3Kα:RAS breaker, alone and in combination with other anti-cancer agents in…NCT06625775·Duarte, California and 43 others

Active not recruitingFirst-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments.NCT03401385·Los Angeles, California and 17 others

RecruitingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors.NCT05579366·Phoenix, Arizona and 65 others

Active not recruitingStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerTo evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the…NCT03937154·Jonesboro, Arkansas and 138 others

CompletedChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerThis randomized phase III clinical trial studies chemotherapy with or without trastuzumab after surgery to see how well they work in treating women with invasive breast cancer.NCT01275677·Anniston, Alabama and 1282 others

CompletedEfficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerPhase I: will look at different dose levels and regimens of everolimus combined with weekly trastuzumab and paclitaxel therapy in patients with HER-2 overexpressing metastatic…NCT00426556·*see Various Departments*, California and 19 others

CompletedTesting Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves SurvivalThis randomized phase II/III trial studies how well standard of care therapy with stereotactic radiosurgery and/or surgery works and compares it to standard of care therapy alone…NCT02364557·Birmingham, Alabama and 161 others

Active not recruitingDoxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerThis randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with…NCT02488967·Mobile, Alabama and 1295 others

CompletedCOM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.This is a Phase 1 open label sequential dose escalation and cohort expansion study evaluating the safety, tolerability and preliminary clinical activity of COM701 as monotherapy…NCT03667716·Los Angeles, California and 10 others

PreviousPage 8 of 10Next

Other Conditions in Los Angeles

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma